Rejected at 2:53 p.m. Oct, 31, 2023 ]
Author: emgleason
Related Note: 1504364393376
Rationale for change

Missing l

Rejection reason

Added via Anki desktop

Text Text
Physeo Physeo
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Bootcamp
OME
Additional Resources
One by one
Empty field
#AK_Step1_v12::#Bootcamp::Dermatology::03_Inflammatory_Diseases_of_the_Skin::02_Reactive_Disease #AK_Step1_v12::#OME::04_Organ_Systems::02_Musculoskeletal::03_Dermatology::05_Skin_and_Soft_Tissue_Infections #PANCE::EOR::Family_med #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Other::#AK_Original_Decks::Step_1::Lolnotacop::Drugs #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs::01_Chronic_gout_drugs_(preventive)::*Allopurinol_Febuxostat #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::08_Drug_reactions-musculoskeletal/skin/connective_tissue #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs::01_Chronic_gout_drugs_(preventive)::*Probenecid #AK_Step1_v12::#FirstAid::11_Musculoskeletal_Skin_and_Connective_Tissue::04_Pharm::09_Gout_drugs #AK_Step1_v12::#OME::Clinical::04_Organ_Systems::02_Musculoskeletal::03_Dermatology::05_Skin_and_Soft_Tissue_Infections #AK_Step1_v12::#Bootcamp::Musculoskeletal::15_Pharmacology::05_Gout_Medications #AK_Step1_v12::#Physeo::09_Pharm::09_Musculoskeletal::08_Acute_and_Chronic_Gout_Treatment #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::02_Gout_Drugs::zanki_extra #PANCE::DERM::acneiform_eruptions #AK_Step1_v12::#SketchyPharm::03_Blood_&_Inflammation::03_Anti-Inflammatory::02_Gout_Drugs #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::14_Probenecid #AK_Step1_v12::#Pixorize::03_Pharmacology::13_Musculoskeletal_Pharm::13_Allopurinol/Febuxostat #PANCE::EOR::IM #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::15_Sulfa_drugs #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step1_v12::^Other::^EXPN